A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Trimethoprim D9 | CAS 1189460-62-5 - Request Quote

Picture of Trimethoprim D9

Trimethoprim D9

SZ CAT No:SZ-T033D02
CAS No
1189460-62-5
Mol.F.
C14H9D9N4O3
Mol.Wt.
299.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Trimethoprim D9 is chemically 5-(3,4,5-tris(methoxy-d3)benzyl)pyrimidine-2,4-diamine. Trimethoprim D9 is supplied with detailed characterization data compliant with regulatory guideline. Trimethoprim D9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Trimethoprim.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1189460-62-5

Purchase 1189460-62-5

Order 1189460-62-5

Enquire 1189460-62-5

price of 1189460-62-5

1189460-62-5 Supplier

1189460-62-5 Manufacturer

1189460-62-5 Exporter

buy high quality Trimethoprim D9

Purchase Trimethoprim D9

Trimethoprim D9 suppliers

Trimethoprim D9 manufacturers

Trimethoprim D9 price

Order Trimethoprim D9

Enquire Trimethoprim D9

Trimethoprim D9 cost

Trimethoprim D9 Supplier

Trimethoprim D9 Distributor

Trimethoprim D9 for Method Validation

Trimethoprim Reference Standard

Trimethoprim D9 for ANDA Filing

Trimethoprim D9 for Forced Degradation Studies

Trimethoprim D9 Identification Standards

Trimethoprim D9 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,